Outcomes of anticoagulant (AC) or antiplatelet (AP) use in patients (pts) with chronic lymphocytic leukemia (CLL) or indolent non-Hodgkin's lymphoma (iNHL) in idelalisib (IDELA) trials Meeting Abstract


Authors: Barrientos, J. C.; Ghia, P.; Pagel, J.; Salles, G. A.; Sharman, J. P.; Stilgenbauer, S.; Gurtovaya, O.; Kim, Y.; Philip, B.; Zelenetz, A. D.
Abstract Title: Outcomes of anticoagulant (AC) or antiplatelet (AP) use in patients (pts) with chronic lymphocytic leukemia (CLL) or indolent non-Hodgkin's lymphoma (iNHL) in idelalisib (IDELA) trials
Meeting Title: 2015 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036901875
PROVIDER: wos
Notes: Meeting Abstract: 8563 -- Source: Wos
MSK Authors
  1. Andrew D Zelenetz
    550 Zelenetz